CytoLynx Therapeutics
About:
CytoLynx Therapeutics is a R&D and commercial platform leveraging Cytovia’s unique technologies and product pipeline.
Website: https://www.cytoviatx.com/cytolynx-therapeutics
Top Investors: YF Capital, TF Capital, BioTrack Capital, Ruihua Venture Capital, Tigermed
Description:
CytoLynx Therapeutics is a R&D and commercial platform leveraging Cytovia’s unique technologies and product pipeline.
Total Funding Amount:
$45M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Shanghai, Shanghai, China
Founded Date:
2021-01-01
Founders:
Laura Hong
Number of Employees:
11-50
Last Funding Date:
2021-09-13
IPO Status:
Private
Industries:
© 2025 bioDAO.ai